Other OTC Pharmaceuticals (Pharmacies) - Turkmenistan

  • Turkmenistan
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$10.48m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.37%, resulting in a market volume of US$11.78m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.59 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Turkmenistan is experiencing significant growth and development.

Customer preferences:
Turkmenistan is a country with a growing population and an increasing demand for healthcare products. As the healthcare system improves and access to healthcare services expands, consumers are becoming more aware of the importance of self-care and are seeking over-the-counter (OTC) pharmaceutical products to address their healthcare needs. Additionally, the convenience and affordability of OTC medications make them a popular choice among consumers in Turkmenistan.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Turkmenistan is the increasing availability and variety of OTC products. Pharmacies are expanding their product offerings to meet the growing demand, providing consumers with a wider range of options for self-care. This trend is driven by both domestic and international pharmaceutical companies, who are recognizing the market potential in Turkmenistan and are actively introducing new OTC products to cater to the needs of the local population. Another trend in the market is the rising popularity of natural and herbal remedies. Consumers in Turkmenistan are increasingly seeking alternative and traditional medicine options, and this is reflected in their preferences for OTC pharmaceutical products. Pharmacies are responding to this trend by stocking a larger selection of natural and herbal remedies, providing consumers with more choices in managing their health and well-being.

Local special circumstances:
Turkmenistan has a unique healthcare system, with a strong emphasis on preventive care and traditional medicine. This cultural and regulatory context influences the development of the Other OTC Pharmaceuticals (Pharmacies) market in the country. Pharmacies in Turkmenistan play a crucial role in providing healthcare services, not only by dispensing medications but also by offering health advice and counseling to consumers. This personalized approach to healthcare contributes to the growing demand for OTC pharmaceutical products.

Underlying macroeconomic factors:
The growing economy of Turkmenistan is also driving the development of the Other OTC Pharmaceuticals (Pharmacies) market. As the country's GDP continues to rise, consumers have more disposable income to spend on healthcare products. This increased purchasing power is fueling the demand for OTC pharmaceuticals, leading to the expansion of the market. Furthermore, the government of Turkmenistan is actively promoting the development of the healthcare sector, including the OTC pharmaceutical market. Initiatives such as the establishment of healthcare centers and the implementation of health education programs are creating a favorable environment for the growth of the market. The government's efforts to improve healthcare infrastructure and services are contributing to the increasing demand for OTC pharmaceutical products in Turkmenistan. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Turkmenistan is experiencing significant growth and development due to increasing customer preferences for self-care, the availability of a wider range of OTC products, the rising popularity of natural and herbal remedies, the unique cultural and regulatory context of the country, and the underlying macroeconomic factors such as the growing economy and government initiatives to improve healthcare services.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)